Jauculan, Rose Mae L.
HRN: 27-17-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CLINDAMYCIN 300MG (CAP)
06/02/2025
06/09/2025
PO
1 Tab
Q6h
Cellulitis, Left Leg
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes